About Us
Our Journey
In the early days, our team focused on research and development in the pharmaceutical sector for our innovative solutions and commitment to patient care. As we refined our processes, our network of healthcare professionals and patients grew, driven by our dedication to improving lives through nature and science.
With each new product launch, our company has continued to innovate, exploring oral cancer therapeutic areas unlocking the therapeutic potential of phytochemicals to create safe, effective, and accessible treatments while remaining dedicated to our core mission.
Development Timeline
Project Milestones
Invivo evaluation on OSMF
Toxicity and safety studies (month 2-12)
Problem and Unmet Need
Disease Complexity
Oral Cancer is a progressive, irreversible condition with a high risk of mortality. The lack of curative options results in severe patient distress.
Current Limitations
Existing treatments like corticosteroids, antioxidants, and surgical interventions fail to address the underlying cellular damage or cancer progression.
Most therapies are palliative, not preventive or curative.
Drug Delivery Challenges
Systemic therapies (e.g., injections or oral pills) lead to poor localization of the active compound, reducing efficacy.
Economic Burden
Non-targeted delivery increases the risk of systemic side effects, lowering patient compliance. Cancer places financial stress on healthcare systems and individuals due to long-term care needs and potential progression to oral cancer.